BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30262257)

  • 1. Axillary Management in Breast Cancer Patients: A Comprehensive Review of the Key Trials.
    Yan M; Abdi MA; Falkson C
    Clin Breast Cancer; 2018 Dec; 18(6):e1251-e1259. PubMed ID: 30262257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary lymph node treatment in breast cancer: an update.
    Williams PA; Suggs J; Mangana SH
    J Miss State Med Assoc; 2014 May; 55(5):145-7. PubMed ID: 25112128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary lymph node dissection can be omitted in patients with limited clinically node-positive breast cancer: a National Cancer Database analysis.
    Cocco D; Shah C; Wei W; Wilkerson A; Grobmyer SR; Al-Hilli Z
    Br J Surg; 2022 Nov; 109(12):1293-1299. PubMed ID: 36066266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional nodal irradiation for early breast cancer; clinical benefit according to risk stratification.
    Bartelink H
    Breast; 2019 Nov; 48 Suppl 1():S65-S68. PubMed ID: 31839164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla.
    Bi Z; Liu J; Chen P; Liu Y; Zhao T; Wang C; Zhang Z; Sun X; Qiu P; Cong B; Song X; Wang Y
    Breast Cancer; 2019 May; 26(3):373-377. PubMed ID: 30666563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Regional Nodal Management of Breast Cancer Patients with Low Nodal Burden.
    Raber BM; Lin H; Shen Y; Shaitelman SF; Bedrosian I
    Ann Surg Oncol; 2019 Dec; 26(13):4346-4354. PubMed ID: 31605340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary approaches to the axilla in breast cancer.
    Thompson JL; Wright GP
    Am J Surg; 2023 Mar; 225(3):583-587. PubMed ID: 36522219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
    Henke G; Knauer M; Ribi K; Hayoz S; Gérard MA; Ruhstaller T; Zwahlen DR; Muenst S; Ackerknecht M; Hawle H; Fitzal F; Gnant M; Mátrai Z; Ballardini B; Gyr A; Kurzeder C; Weber WP
    Trials; 2018 Dec; 19(1):667. PubMed ID: 30514362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy.
    Cao XS; Li HJ; Cong BB; Sun X; Qiu PF; Liu YB; Wang CJ; Wang YS
    Oncotarget; 2016 Nov; 7(45):74074-74081. PubMed ID: 27738336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy?
    Kantor O; Pesce C; Liederbach E; Wang CH; Winchester DJ; Yao K
    Breast J; 2017 Sep; 23(5):554-562. PubMed ID: 28295828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Complete Axillary Node Dissection Be Safely Omitted in Patients with Early Breast Cancer When the Sentinel Node Biopsy Is Positive for Malignancy? An Update for Clinical Practice.
    Gera R; Kasem A; Mokbel K
    In Vivo; 2018; 32(6):1301-1307. PubMed ID: 30348682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer.
    Zetterlund L; Celebioglu F; Axelsson R; de Boniface J; Frisell J
    Breast Cancer Res Treat; 2017 May; 163(1):93-101. PubMed ID: 28213781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Experience of Axillary Radiotherapy for Node-positive Breast Cancer.
    Anderson S; Peters AL; Lumsden G; Alhasso A; Cartwright D; O'Brien O; Marashi H
    Clin Oncol (R Coll Radiol); 2024 Feb; 36(2):98-106. PubMed ID: 38057203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trade-offs associated with axillary lymph node dissection with breast irradiation versus breast irradiation alone in patients with a positive sentinel node in relation to the risk of non-sentinel node involvement: implications of ACOSOG Z0011.
    Krishnan MS; Recht A; Bellon JR; Punglia RS
    Breast Cancer Res Treat; 2013 Feb; 138(1):205-13. PubMed ID: 23338762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
    Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
    Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice.
    El Hage Chehade H; Headon H; Kasem A; Mokbel K
    Anticancer Res; 2016 Apr; 36(4):1461-71. PubMed ID: 27069121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional radiotherapy after primary systemic treatment for cN+ breast cancer patients.
    Boersma LJ; Mjaaland I; van Duijnhoven F
    Breast; 2023 Apr; 68():181-188. PubMed ID: 36805769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice Patterns of Radiation Field Design for Sentinel Lymph Node-Positive Early-Stage Breast Cancer.
    Azghadi S; Daly M; Mayadev J
    Clin Breast Cancer; 2016 Oct; 16(5):410-417.e3. PubMed ID: 27266803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.